Filter
269
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
15
New Publications
65
Language
Document type
No document type
112
Studies & Reports
72
Guidelines
42
Manuals
23
Strategic & Response Plan
14
Fact sheets
4
Situation Updates
2
Countries / Regions
Kenya
24
Nigeria
9
South Africa
9
Liberia
7
Ghana
7
Uganda
7
Zimbabwe
7
India
7
Ethiopia
6
Sierra Leone
5
Tanzania
5
Bangladesh
5
Western and Central Europe
5
Philippines
4
Zambia
4
Malawi
4
Botswana
4
Global
4
Senegal
3
Nepal
3
Syria
3
Rwanda
3
Ukraine
3
Eastern Europe and Central Asia
3
Cambodia
2
Indonesia
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
Myanmar / Burma
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Cameroon
1
Haiti
1
Thailand
1
Sudan
1
Brazil
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Asia
1
Africa
1
Eastern Europe
1
Moldova
1
North America
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
140
Clinical Guidelines
16
Pharmacy & Technologies
11
Public Health
10
Key Resources
6
Women & Child Health
5
Capacity Building
1
Toolboxes
Pharmacy
49
AMR
48
COVID-19
19
Mental Health
8
TB
7
HIV
5
Ebola
3
Conflict
3
Caregiver
3
NTDs
3
Global Health Education
2
Planetary Health
2
Disability
1
Natural Hazards
1
Rapid Response
1
Refugee
1
Health Financing Toolbox
1
NCDs
1
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight
...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affor
...
Revision Bulletin ESPNF
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Drug Distribution and Control: Preparation and Handling–Guidelines
Review 2008
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availa
...
Prices people pay for medicines.
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provi
...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
